Previous 10 | Next 10 |
The S&P 500 was down 2.2% last week, which, in normal times, would be barely worth a mention. But in today’s speculative market, that qualifies as a correction. The first two quarters of this year were a big rebound, but last quarter was a bummer with the emergence of the D...
We recently rebalanced many of our WisdomTree international equity Indexes as part of their annual reconstitution process. As a result of the 2021 rebalance, the broad market and large-cap Indexes exhibited modest changes of 2% or less across all sectors compared to their pre-rebalanc...
Nine-month results of Sartorius Stedim Biotech - Sales revenue up 56.2 percent to 2,109 million euros; underlying EBITDA margin 36.3 percent - Dynamic and profitable organic growth; significant demand momentum generated by the production of coronavirus vaccines as well as st...
WisdomTree International MidCap Dividend Fund (NYSEARCA:DIM) - $0.8500. 30-Day SEC Yield of 2.49% as of Sept. 23. Payable Sep 29; for shareholders of record Sep 29; ex-div Sep 29. For further details see: WisdomTree International MidCap Dividend Fund declares quarterly distribution of $...
McMaster, Sartorius Stedim Biotech team up to advance biomanufacturing processes with next-gen tech PR Newswire HAMILTON, ON and AUBAGNE, France , Aug. 23, 2021 /PRNewswire/ -- Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical...
Sartorius Stedim Biotech acquires cell culture specialist Xell AG - Extension of the Sartorius Stedim Biotech cell culture media business with a focus on media for gene therapeutics and vaccines - Significant expansion of capacities for manufacturing dry powder and liquid me...
Half-year results of Sartorius Stedim Biotech - Sales revenue up 61.1 percent to 1,352 million euros; underlying EBITDA margin 36.1 percent - Dynamic organic growth; added momentum from pandemic-related business and acquisitions - Forecast for 2021 raised yet again at th...
Sartorius Stedim Biotech provides preliminary first-half financial key figures and raises forecast for 2021 Sartorius Stedim Biotech announces today that it expects strong first-half performance and raises its forecast for the full year of 2021. Disclosure of inside informat...
Sartorius Stedim Biotech strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix - Portfolio expanded by cell culture components, such as growth factors, cytokines, and media - CellGenix site in Freiburg to be expanded into a cent...
WisdomTree International MidCap Dividend Fund (DIM) - $6.3600.30-Day SEC Yield of 2.55% as of June 23.Payable Jun 29; for shareholders of record Jun 25; ex-div Jun 24. For further details see: WisdomTree International MidCap Dividend Fund declares quarterly distribution of $6.3600
News, Short Squeeze, Breakout and More Instantly...
WisdomTree International MidCap Dividend Fund Company Name:
DIM Stock Symbol:
NYSE Market:
WisdomTree International MidCap Dividend Fund Website:
2024-05-30 08:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-30 14:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-10 21:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...